StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by KPOIndustrieson Apr 14, 2020 9:26am

41 Views

Post# 30906692

RE:RE:RE:Where is the test update? Progress...

once again, that's BS. They can update us on what they are doing in a news release. Go to SONA they are transparent and show progression. Every company, other than StageZero, provides progress news releases. These guys don't give us anything. It's been two weeks. You can't tell us if you have talked to the governments??? Right now it says they were preparing to talk. Ok now what??????????????????????

Blackspar0w wrote: Thank you for your email. We will provide updates as soon as we can. I appreciate that many people, shareholders and others are eager to hear of our progress.

Rebecca

Rebecca Greco
Investor Relations

8751 Park Central Drive, Suite 200

Richmond, VA 23227

Phone: +1-855-420-7140 ext. 1838